BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22530086)

  • 41. In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method.
    Lu JJ; Lee SY; Chiueh TS
    J Microbiol Immunol Infect; 2004 Dec; 37(6):335-42. PubMed ID: 15599465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
    Marco F; Danés C; Almela M; Jurado A; Mensa J; de la Bellacasa JP; Espasa M; Martínez JA; Jiménez de Anta MT
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):259-64. PubMed ID: 12944017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC; Chen YH; Chen YC; Lu PL
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro susceptibilities to caspofungin and micafungin of clinical isolates of Candida species.].
    Choi HW; Shin JH; Lee JS; Cho D; Shin MG; Suh SP; Ryang DW
    Korean J Lab Med; 2006 Aug; 26(4):275-81. PubMed ID: 18156738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D; Watelle M; Nolard N
    Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
    Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.
    Shi XY; Yang YP; Zhang Y; Li W; Wang JD; Huang WM; Fan YM
    J Med Microbiol; 2015 Apr; 64(Pt 4):390-393. PubMed ID: 25596116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
    Lei J; Xu J; Wang T
    J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
    Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey.
    Yenisehirli G; Bulut N; Yenisehirli A; Bulut Y
    Jundishapur J Microbiol; 2015 Sep; 8(9):e28057. PubMed ID: 26495115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis.
    Song YB; Suh MK; Ha GY; Kim H
    Ann Dermatol; 2015 Dec; 27(6):715-20. PubMed ID: 26719641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antifungal susceptibilities of Candida species isolated from urine culture.
    Toka Özer T; Durmaz S; Yula E
    J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital.
    Bonfietti LX; Szeszs MW; Chang MR; Martins MA; Pukinskas SR; Nunes MO; Pereira GH; Paniago AM; Purisco SU; Melhem MS
    Mycopathologia; 2012 Dec; 174(5-6):389-96. PubMed ID: 22821345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.